1. Levetiracetam: risk of suicidality

   News item 17 June 2017 Pages: 1 - 1

2. Medsafe reports of hepatic reactions with quetiapine

   News item 17 June 2017 Pages: 2 - 2

3. Mibelas 24 Fe batch recalled due to packaging error

   News item 17 June 2017 Pages: 3 - 3

4. Miconazole oral gel: labelling to warn of warfarin interaction

   News item 17 June 2017 Pages: 4 - 4

5. Noscapine may cause pain

   News item 17 June 2017 Pages: 5 - 5

6. Olanzapine may cause DRESS

   News item 17 June 2017 Pages: 6 - 6

7. Risk of permanent adverse events with mefloquine

   News item 17 June 2017 Pages: 7 - 7

8. Adverse events with systemic or intravitreal anti-VEGF drugs

   Clinical study 17 June 2017 Pages: 8 - 8

9. In utero exposure to lithium risks cardiac malformations

   Clinical study 17 June 2017 Pages: 9 - 9

10. Metabolic events with second-generation antipsychotics

    Clinical study 17 June 2017 Pages: 10 - 10

11. Mortality not increased with incretin-based therapy in T2DM

    Clinical study 17 June 2017 Pages: 11 - 11

12. SGLT2 inhibitors increase risk of diabetic ketoacidosis

    Clinical study 17 June 2017 Pages: 12 - 12

13. Statins: liver safety in patients with NASH, T2DM

    Clinical study 17 June 2017 Pages: 13 - 13

14. Venlafaxine associated with accelerated bone loss

    Clinical study 17 June 2017 Pages: 14 - 14

15. 90Y-DOTATATE/iobenguane/octreotate-Lu-177-DOTA-Tyr-3

    Case report 17 June 2017 Pages: 15 - 15

16. Abatacept

    Case report 17 June 2017 Pages: 16 - 16

17. Abatacept

    Case report 17 June 2017 Pages: 17 - 17

18. Aciclovir

    Case report 17 June 2017 Pages: 18 - 18

19. Adalimumab

    Case report 17 June 2017 Pages: 19 - 19

20. Adalimumab

    Case report 17 June 2017 Pages: 20 - 20

21. Afatinib

    Case report 17 June 2017 Pages: 21 - 21

22. Afatinib

    Case report 17 June 2017 Pages: 22 - 22

23. Aflibercept/ranibizumab

    Case report 17 June 2017 Pages: 23 - 23

24. Ajmaline/lamotrigine interaction

    Case report 17 June 2017 Pages: 24 - 24

25. Alemtuzumab

    Case report 17 June 2017 Pages: 25 - 25

26. Alemtuzumab

    Case report 17 June 2017 Pages: 26 - 26

27. Alemtuzumab

    Case report 17 June 2017 Pages: 27 - 27

28. Alemtuzumab

    Case report 17 June 2017 Pages: 28 - 28

29. Alendronic acid/anastrozole/zoledronic acid

    Case report 17 June 2017 Pages: 29 - 29

30. Alendronic-acid

    Case report 17 June 2017 Pages: 30 - 30

31. Allopurinol

    Case report 17 June 2017 Pages: 31 - 31

32. Allopurinol/carbamazepine

    Case report 17 June 2017 Pages: 32 - 32

33. Allopurinol/carbamazepine/dapsone/phenytoin

    Case report 17 June 2017 Pages: 33 - 33

34. Amfetamine/Citalopram/clonidine

    Case report 17 June 2017 Pages: 34 - 34

35. Amiodarone/flecainide/sotalol

    Case report 17 June 2017 Pages: 35 - 35

36. Amitriptyline/cimetidine/indometacin

    Case report 17 June 2017 Pages: 36 - 36

37. Amoxicillin

    Case report 17 June 2017 Pages: 37 - 37

38. Amoxicillin/clavulanic acid

    Case report 17 June 2017 Pages: 38 - 38

39. Amoxicillin/clavulanic acid/rivaroxaban

    Case report 17 June 2017 Pages: 39 - 39

40. Amoxicillin/clavulanic-acid

    Case report 17 June 2017 Pages: 40 - 40

41. Amphotericin-b

    Case report 17 June 2017 Pages: 41 - 41

42. Amphotericin-B

    Case report 17 June 2017 Pages: 42 - 42

43. Ampicillin

    Case report 17 June 2017 Pages: 43 - 43

44. Anakinra/canakinumab

    Case report 17 June 2017 Pages: 44 - 44

45. Anthracyclines/trastuzumab

    Case report 17 June 2017 Pages: 45 - 45

46. Antineoplastics

    Case report 17 June 2017 Pages: 46 - 46

47. Antineoplastics

    Case report 17 June 2017 Pages: 47 - 47

48. Antineoplastics

    Case report 17 June 2017 Pages: 48 - 48

49. Antineoplastics

    Case report 17 June 2017 Pages: 49 - 49

50. Antineoplastics

    Case report 17 June 2017 Pages: 50 - 50